MercadoLibre (MELI) Stock Sinks As Market Gains: Here's Why — Negative
MELI Zacks Investment Research — February 11, 2025MercadoLibre (MELI) concluded the recent trading session at $2,035.18, signifying a -0.34% move from its prior day's close.
Nike (NKE) Rises Higher Than Market: Key Facts — Neutral
NKE Zacks Investment Research — February 11, 2025Nike (NKE) concluded the recent trading session at $71.34, signifying a +0.56% move from its prior day's close.
Nvidia (NVDA) Stock Falls Amid Market Uptick: What Investors Need to Know — Negative
NVDA Zacks Investment Research — February 11, 2025In the most recent trading session, Nvidia (NVDA) closed at $132.80, indicating a -0.58% shift from the previous trading day.
Adobe Systems (ADBE) Laps the Stock Market: Here's Why — Neutral
ADBE Zacks Investment Research — February 11, 2025Adobe Systems (ADBE) concluded the recent trading session at $458.82, signifying a +1.71% move from its prior day's close.
Siga Technologies Inc. (SIGA) Stock Drops Despite Market Gains: Important Facts to Note — Neutral
SIGA Zacks Investment Research — February 11, 2025In the closing of the recent trading day, Siga Technologies Inc. (SIGA) stood at $6.03, denoting a -0.66% change from the preceding trading day.
Petrobras (PBR) Surpasses Market Returns: Some Facts Worth Knowing — Positive
PBR Zacks Investment Research — February 11, 2025Petrobras (PBR) reachead $14 at the closing of the latest trading day, reflecting a +0.79% change compared to its last close.
Alibaba (BABA) Exceeds Market Returns: Some Facts to Consider — Neutral
BABA Zacks Investment Research — February 11, 2025In the latest trading session, Alibaba (BABA) closed at $112.78, marking a +1.31% move from the previous day.
ODP Corp. (ODP) Stock Slides as Market Rises: Facts to Know Before You Trade — Negative
ODP Zacks Investment Research — February 11, 2025The latest trading day saw ODP Corp. (ODP) settling at $20.12, representing a -1.32% change from its previous close.
Gladstone Capital (GLAD) Misses Q1 Earnings and Revenue Estimates — Negative
GLAD Zacks Investment Research — February 11, 2025Gladstone Capital (GLAD) came out with quarterly earnings of $0.50 per share, missing the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.54 per share a year ago.
Freshworks Inc. (FRSH) Q4 Earnings and Revenues Surpass Estimates — Positive
FRSH Zacks Investment Research — February 11, 2025Freshworks Inc. (FRSH) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.08 per share a year ago.
Teradata (TDC) Surpasses Q4 Earnings Estimates — Positive
TDC Zacks Investment Research — February 11, 2025Teradata (TDC) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.56 per share a year ago.
Primerica (PRI) Surpasses Q4 Earnings and Revenue Estimates — Positive
PRI Zacks Investment Research — February 11, 2025Primerica (PRI) came out with quarterly earnings of $5.03 per share, beating the Zacks Consensus Estimate of $4.96 per share. This compares to earnings of $4.25 per share a year ago.
Kite Realty Group (KRG) Q4 FFO Match Estimates — Positive
KRG Zacks Investment Research — February 11, 2025Kite Realty Group (KRG) came out with quarterly funds from operations (FFO) of $0.53 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.50 per share a year ago.
Tigo Energy, Inc. (TYGO) Reports Q4 Loss, Tops Revenue Estimates — Negative
TYGO Zacks Investment Research — February 11, 2025Tigo Energy, Inc. (TYGO) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.25 per share a year ago.
Highwoods Properties (HIW) Q4 FFO Match Estimates — Positive
HIW Zacks Investment Research — February 11, 2025Highwoods Properties (HIW) came out with quarterly funds from operations (FFO) of $0.85 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.99 per share a year ago.
Investors who lost money on Grocery Outlet Holding Corp.(GO) should contact Levi & Korsinsky about pending Class Action - GO — Neutral
GO Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=128815&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Announces an Investigation on Behalf of Dominion Energy, Inc. (D) Shareholders Who May Have Been Affected by Fraud — Neutral
D Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Dominion Energy, Inc. ("Dominion Energy, Inc.") (NYSE:D) concerning possible violations of federal securities laws. On February 3, 2025, Dominion issued a press release providing updates for its Coastal Virginia Offshore Wind (CVOW) project.
Did Construction Partners, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - ROAD — Neutral
ROAD Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Construction Partners, Inc. ("Construction Partners, Inc.") (NASDAQ:ROAD) concerning possible violations of federal securities laws. On January 23, 2025, Spruce Point Capital Management published a report highlighting the increasing pressures faced by Construction Partners suggesting that the share price could have a 35-50% potential long-term downside risk.
Class Action Filed Against Pacira BioSciences, Inc. (PCRX) - March 14, 2025 Deadline to Join - Contact Levi & Korsinsky — Neutral
PCRX Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=128810&wire=1 or contact Joseph E. Levi, Esq.
